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Decreased HIV-specific CD8+ T cell proliferation is a
hallmark of chronic infection, but the mechanisms of
decline are unclear. We analyzed gene expression
profiles from antigen-stimulated HIV-specific CD8+
T cells from patients with controlled and uncontrolled
infection and identified caspase-8 as a correlate of
dysfunctional CD8+ T cell proliferation. Caspase-8
activity was upregulated in HIV-specific CD8+ T cells
from progressors and correlated positively with
disease progression and programmed cell death-1
(PD-1) expression, but negatively with proliferation.
In addition, progressor cells displayed a decreased
ability to upregulate membrane-associated cas-
pase-8 activity and increased necrotic cell death
following antigenic stimulation, implicating the pro-
grammed cell death pathway necroptosis. In vitro
necroptosis blockade rescued HIV-specific CD8+
T cell proliferation in progressors, as did silencing of
necroptosis mediator RIPK3. Thus, chronic stimu-
lation leading to upregulated caspase-8 activity con-
tributes to dysfunctional HIV-specific CD8+ T cell
proliferation through activation of necroptosis and
increased cell death.
INTRODUCTION
HIV-specific CD8+ T cells have been strongly implicated in viral
control, particularly in individuals who naturally suppress viremia
to undetectable levels known as ‘‘elite controllers’’ (ECs) (Walker
and Yu, 2013). While numerous qualitative features of CD8+ImmT cells have been identified in controllers, such as increased
polyfunctionality and elevated expression of cytotoxic effector
molecules, their robust proliferation in response to antigenic
stimulation is among the most important correlates of immune
control and delayed disease progression (Migueles et al.,
2002, 2008; Lichterfeld et al., 2004; Betts et al., 2006; Day
et al., 2007; McKinnon et al., 2012). Recent data utilizing a
high-dimensional immune monitoring model demonstrated that
HIV-specific CD8+ T cell proliferation was the strongest single
determinant of spontaneous viral control (Ndhlovu et al., 2013),
while previous work illustrated that proliferative capacity is
directly linked to the enhanced cytotoxicity observed in ex vivo
inhibition assays (Migueles et al., 2002, 2008).
In the vast majority of individuals, however, chronic infection
leads to a decline in HIV-specific CD8+ T cell proliferative ca-
pacity due to the development of intrinsic CD8+ T cell defects
(Migueles et al., 2002; Day et al., 2007; Wherry, 2011). HIV-spe-
cific CD8+ T cells from chronic progressors (CP) exhibit elevated
expression of inhibitory immunoregulatory receptors, such as
programmed cell death-1 (PD-1), 2B4, and T cell immunoglob-
ulin domain and mucin domain-3 (Tim-3) (Day et al., 2006; Traut-
mann et al., 2006; Yamamoto et al., 2011; Pacheco et al., 2013),
resulting in T cell exhaustion and reduced proliferative capacity.
Recent work has also highlighted the role of transcription factors
such as BATF (basic leucine transcription factor, ATF-like) and
NFAT (nuclear factor of activated T cells) in mediating impaired
proliferative states (Migueles et al., 2008; Quigley et al., 2010).
While proliferation can be partially restored through blockade
of PD-1 (Day et al., 2006) or by increased nuclear translocation
of NFAT (Migueles et al., 2008), the molecular mechanisms
that govern this diminished response are poorly understood.
Thus, we sought to further characterize the molecular pathways
that differentiate the highly proliferative responses in ECs from
the dysfunctional HIV-specific CD8+ T cell responses that
develop in CPs.unity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Inc. 1001
Immunity
Necroptosis Limits HIV-Specific CTL ProliferationTo accomplish this, we performed whole-genome transcrip-
tional profiling on HIV tetramer+ CD8+ T cells from patients with
controlled and uncontrolled infection following stimulation with
cognate antigen. We sorted HIV-specific CD8+ T cells from four
HLA-B*2705+ ECs and four HLA-B*2705+ CPs, in the presence
and absence of the immunodominant B*2705-restricted Gag
p24 KK10 (amino acids 263–272) epitope. Gene expression anal-
ysis revealed a unique set of genes that were differentially ex-
pressed in KK10-specific EC and CP CD8+ T cells following
6 day peptide stimulation. Further refinement of this list using
an in silico approach (DAPPLE) (Rossin et al., 2011) revealed
genes directly involved in protein-protein network connectivity,
which included the aspartate-specific cysteine protease cas-
pase-8.While caspase-8 has primarily been associatedwith acti-
vation-induced cell death (AICD) mediated by Fas/CD95 (Green
et al., 2003; Wilson et al., 2009), it also plays a nonredundant
role in CD8+ T cell proliferation by suppressing the endogenous
necrotic cell death pathway necroptosis following TCR activation
(Salmena et al., 2003; Leverrier et al., 2011; Ch’en et al., 2011).
These distinct roles for caspase-8 are regulated by cellular com-
partmentalization, with membrane-associated caspase-8 (in
association with c-FLIP(L)) playing a key role in inhibiting the for-
mation of the receptor-interacting protein kinase-1/3 complex
(RIPK1, RIPK3) that mediates necroptosis (Misra et al., 2007,
Cho et al., 2009; Oberst et al., 2011; Koenig et al., 2014).
In our study, CP HIV-specific CD8+ T cells had elevated levels
of caspase-8 activity, which was predominantly localized in the
cytoplasm and correlated strongly with impaired proliferation.
CP HIV-specific CD8+ T cells also displayed decreased upregu-
lation of membrane-associated caspase-8 activity following
T cell receptor (TCR) stimulation and consequently an increase
in necrotic cell death. Blockade of necroptosis by chemical
inhibition reversed the proliferative defect, which was further
validated by the improvement in proliferation following shRNA-
mediated silencing of RIPK3. Collectively, these data suggest
that necroptosis plays a previously undefined role in mediating
dysfunctional HIV-specific CD8+ T cell proliferation in chronic
HIV infection.
RESULTS
Transcriptional Profiling Differentiates Peptide-
Stimulated HIV-Specific CD8+ T Cells from ECs and CPs
To elucidate themechanisms underlying functional and dysfunc-
tional HIV-specific CD8+ T cell proliferation, we focused on CD8+
T cells specific for the HLA-B*2705-restricted Gag p24 KK10
epitope within a group of B*2705 ECs (n = 4) and CPs (n = 4;
Table S1). We selected this epitope because of its strong asso-
ciation with the protective features of HLA-B*2705 (Goulder
et al., 1997; Kelleher et al., 2001), its high immunodominance
(Streeck et al., 2009), and the marked difference in KK10
tetramer+ CD8+ T cell proliferation following 6 day peptide stim-
ulationwithin our two patient groups (p = 0.029; Figure 1A). Given
these striking differences, we chose to further analyze these
patients’ responses by performing transcriptional profiling
following 6 day KK10 peptide stimulation on three sorted popu-
lations: (1) peptide-stimulated KK10 tetramer+ CD8+ T cells, (2)
non-peptide-stimulated KK10 tetramer+ CD8+ T cells, and (3)
peptide-stimulated bulk CD8+ T cells (Figure S1B).1002 Immunity 41, 1001–1012, December 18, 2014 ª2014 Elsevier InAnalysis of differentially expressed genes between peptide-
stimulated and non-peptide-stimulated KK10 tetramer+ CD8+
T cells revealed a strong effector phenotype in controllers (n =
284 genes; Table S2; Figure S2A), while progressors were en-
riched for interferon-related genes and zinc finger transcription
factors, which is characteristic of a persistently activated state
(n = 92 genes; Table S2) (Wherry et al., 2007). However, to pref-
erentially identify those genes involved in functional and
dysfunctional CD8+ T cell proliferation, we focused on tran-
scripts that differentiated EC and CP peptide-stimulated KK10
tetramer+ CD8+ T cells (n = 136 genes; Table S2; Figure 1B).
This comparison revealed that proliferating EC KK10 tetramer+
CD8+ T cells were enriched for genes involved in mitosis, cell cy-
cle, and DNA double-strand break repair, while CP cells were en-
riched for genes involved in T lymphocyte homeostasis and
constitutive T cell activation (Tables S2 and S3).
We next compared these results in humans to the well-defined
murine lymphocytic choriomeningitis virus (LCMV)model (Doering
et al., 2012) during infectionwith two strains of LCMV: LCMVArm-
strong (Arm), which results in an acute infection, and LCMVClone
13 (Cl13), which results in a persistent infection. Transcriptional
profiles ofCD8+T cells specific for the LCMVepitopeDbGP33dur-
ing LCMV Arm infection were noted to be highly similar to the ge-
netic signature of EC cells. These included genes involved in cell
cycle,mitosis, DNA replication, and DNA repair. In addition, genes
upregulated in GP33-specific CD8+ T cells isolated during LCMV
Cl13 infection were enriched in the CP gene set. These included
markers of activation (CD44, CD74, LAT2), regulators of T cell ho-
meostasis (CASP8, IL7R) and transcription factors (IKZF2).
Furthermore, the CP gene signature contained genes involved in
constitutive T cell activation (SRC, LYN, and FYB), which are rarely
expressed in T cells except during pathogenic states such as leu-
kemiaand lymphoma(Weiletal., 1999).Thiswassimilar to the tran-
scriptional phenotype of LCMV Cl13 GP33-specific CD8+ T cells,
which lacked a subset of quiescence genes allowing them to
disarm activation and return to homeostasis (Doering et al., 2012).
To rigorously test these associations, we performed gene set
enrichment analyses (GSEA) (Subramanian et al., 2005) between
our EC andCP gene sets and the transcriptional profiles of LCMV
Arm and Cl13 GP33-specific CD8+ T cells. Gene expression sig-
natures of GP33-specific CD8+ T cells were available at a number
of time points (days 6, 8, 15, and 30). We therefore performed
GSEAs between all permutations of day 6–30 LCMV Arm and
Cl13 gene sets and our peptide-stimulated EC and CP KK10
tetramer+ CD8+ T cell transcriptional profiles.We found the stron-
gest enrichments between the day 6 LCMV Arm and our EC
signature, and between the day 15 LCMVCl13 and our CP signa-
ture (FDR q value < 0.25; Figures 1C and 1D). These data
confirmed a likeness between the transcriptional profiles of HIV-
specific and LCMV-specific CD8+ T cells during chronic infection
(Quigley et al., 2010), demonstrating the similarity in the genetic
signatures of LCMV Arm-specific and antigen-stimulated EC
HIV-specific CD8+ T cells, while also validating the transcriptional
differences between peptide-stimulated EC and CP cells.
Network Analysis Identifies Key Upregulated Genes in
HIV-Specific CD8+ T Cells
To further evaluate our differential gene list, we made use of an
in silico network analysis platform (DAPPLE) (Rossin et al.,c.
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Figure 1. Transcriptional Profiling Analysis of Peptide-Stimulated HIV-Specific CD8+ T Cells from ECs and CPs
(A) Histograms of gated viable CD8+ KK10 tetramer+ T lymphocytes in B*2705 controllers and CPs stimulated with KK10 peptide (10 ng/ml). Numbers over
bracketed lines indicate the percentages of the gated population (KK10 Tetramer+ CD8+ T cells) that have undergone at least one cell division after 6 days in
culture.
(B) The top differentially expressed genes in peptide-stimulated EC andCPKK10 tetramer+ CD8+ T cells are shown. Each column represents an individual sample
and each row an individual gene, colored to indicate normalized expression (blue = increased expression, yellow = decreased expression).
(C and D) Gene set enrichment analysis of upregulated gene sets in ECs and CPs with day 6 LCMV Arm-specific CD8+ T cells (Acute LCMV) and day 15 LCMV
Cl13-specific CD8+ T cells (Chronic LCMV). The upregulated genes in HIV-specific CD8+ T cells from ECs were strongly enriched in the Acute LCMV Armstrong
gene set (FDR q value < 0.25). The upregulated genes in HIV-specific CD8+ T cells fromCPswere strongly enriched in the Chronic LCMVClone 13 gene set (FDR q
value < 0.25). The vertical blue and red bars indicate the individual genes that are enriched in both gene sets.
(E and F) Direct and indirect DAPPLE networks built from upregulated gene expression sets from peptide-stimulated ECs (blue) and CPs (red) using known high-
confidence pairwise protein-protein interactions (Rossin et al., 2011; Lage et al., 2007). See also Tables S2 and S3.
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list as defined by InWeb (Lage et al., 2007). We performed
distinct analyses on the upregulated genes in the EC and CP sig-
natures, which revealed that each gene set exhibited signifi-
cantly greater direct connectivity than would be expected by
chance (EC upregulated genes, p < 0.001; CP upregulated
genes, p < 0.05; Figures 1E and 1F). Genes involved in each
direct network, which were identified as primary drivers of overall
network connectivity, revealed 16 candidate genes in the EC
network (SPC25, MLF1IP, BUB1B, RAD51, RAD51AP1,
C1orf59, BRCA1, RPA3, PRIM1, THOC4, MND1, CKS2,
CKS1B, CCNB2, LMNB1, and UBASH3A) and 11 candidate
genes in the CP network (APP, CASP8, SRC, FYB, LYN, IL-7R,
AKAP13, THRA, CD44, CD74, and HLA-DQA1) (Table S3). For
our analysis, we focused on genes potentially involved inImmdysfunctional HIV-specific CD8+ T cell proliferation. We there-
fore selected caspase-8 (Casp8) for further evaluation given
the aforementioned DAPPLE analysis, its known role in regu-
lating T cell homeostasis (Salmena et al., 2003), and also its
involvement in 7 of the 10 most significant CP gene ontology
pathways (Figure S2B).
Caspase-8 Activity Is Associated with HIV Disease
Progression
Caspase-8, an aspartate-specific cysteine protease, has a well-
established role in apoptosis following activation of death recep-
tors, such as Fas (Wilson et al., 2009). However, it also plays an
essential role in antigen-induced T cell proliferation by suppress-
ing necroptosis at the cell membrane (Salmena et al., 2003; Lev-
errier et al., 2011; Ch’en et al., 2011). To define the role ofunity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Inc. 1003
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Figure 2. Caspase-8 Activity Is Upregulated in HIV-Specific CD8+ T Cells and Is Associated with Disease Progression
(A) Real-time qPCR measurement of caspase-8 expression relative to GAPDH expression from sorted peptide-stimulated HIV tetramer+ CD8+ T cells from ECs
(n = 7) and CPs (n = 7). Filled symbols represent HLA-B*2705 KK10 tetramer+ responses and open symbols represent HLA-B*5701 KF11 Tetramer+ responses.
Relative expression was calculated using the 2DDCt method (Livak and Schmittgen, 2001). Statistical analysis was made using the Mann-Whitney test.
(B) Representative caspase-8mean fluorescence intensity (MFI) values of KK10 tetramer+ CD8+ T cells in three HLA-B*2705 HIV+ patients with diverse viral loads.
(C) Relative mean fluorescence intensity (MFI) of caspase-8 activity on HIV tetramer+ CD8+ T cells from ECs (n = 9), VCs (n = 7), and CPs (n = 15). Filled symbols
represent HLA-B*2705 KK10-specific response, open symbols represent HLA-B*5701 KF11-specific responses, and gray symbols represent non-HLA B*2705/
non-HLA B*5701 responses. Horizontal bars indicate meanMFI of caspase-8 activity. Kruskal-Wallis test was used for comparison among all groups of subjects;
the Dunns posttest was used for comparisons between groups.
(D) Positive correlation between MFI of caspase-8 activity of HIV tetramer+ CD8+ T cells and viral load (n = 31).
(E) Negative correlation between MFI of caspase-8 activity of HIV tetramer+ CD8+ T cells and CD4+ T cell count (n = 31).
(F) Caspase-8 activity decreases in HIV tetramer+ CD8+ T cells following initiation of HAART (n = 9). Statistical comparisons were made using the Wilcoxon
matched pairs test.
(G) Positive correlation between MFI of caspase-8 activity and MFI of PD-1 expression on HIV-specific CD8+ T cells (n = 21).
(H) Mean fluorescence intensity of caspase-8 activity of A*0201 SL9 tetramer+ CD8+ T cells compared with A*0201 CMV pp65 NV9 tetramer+ CD8+ T cells and
total CD8+ T cells in patients naive from antiretroviral therapy (n = 18), and total CD8+ T cells from A*0201 HIV-seronegative controls (n = 9). Repeated-measures
(legend continued on next page)
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Necroptosis Limits HIV-Specific CTL Proliferationcaspase-8 in dysfunctional HIV-specific CD8+ T cell proliferation,
we first confirmed differences in caspase-8 gene expression by
qRT-PCR within sorted peptide-stimulated HIV tetramer+ CD8+
T cells from a group of ECs (n = 7) and CPs (n = 7) distinct
from those used in our transcriptional profiling studies. Measure-
ments of caspase-8 transcript expression were carried out rela-
tive to GAPDH expression and revealed significantly higher
Casp8/GAPDH expression in peptide-stimulated CP tetramer+
CD8+ T cells in comparison to peptide-stimulated EC cells (p =
0.027; Figure 2A), which was consistent with our transcriptional
profiling data (Table S2).
We next measured the mean fluorescence intensity (MFI)
of caspase-8 activity in HIV tetramer+ CD8+ T cells directed
against four immunodominant epitopes—HLA-B*2705 KK10,
HLA-B*5701-restricted Gag p24 KF11 (amino acids 162–172),
HLA-A*0201-restricted Gag p17 SL9 (amino acids 77–85), and
HLA-B*0801-restricted Nef FL8 (amino acids 90–97)—using the
cell-permeable, fluorescently labeled caspase-8 probe FAM-
LETD-FMK, which selectively binds only to active caspase-8 mol-
ecules (Figures 2B and 2C) (Ekert et al., 1999).Within a group of 31
treatment-naive HIV+ individuals, which consisted of ECs,
‘‘viremic controllers’’ (VCs; with viral loads between 50 and
2,000 RNA copies/ml), and CPs, we found that caspase-8 activity
in HIV tetramer+ CD8+ T cells was significantly higher in CPs in
comparison to both ECs (p < 0.001) and VCs (p < 0.05). Examina-
tion of HIV tetramer+ CD8+ T cell caspase-8 activity and markers
of disease progression revealed a positive correlation between
caspase-8 MFI and viral load (p < 0.0001; Figure 2D) and a nega-
tive correlation with CD4+ T cell count (p = 0.0003; Figure 2E).
Analysis of the effect of highly active antiretroviral therapy
(HAART) on caspase-8 activity in nine CPs, for whom peripheral
bloodmononuclear cells (PBMCs) were available before and after
the initiation of treatment, revealed a significant decrease in cas-
pase-8 MFI similar to that observed in ECs and VCs, coincident
with the decline in plasma viral load (p < 0.05; Figure 2F). Cas-
pase-8 MFI of HIV tetramer+ CD8+ T cells was also significantly
correlatedwith theMFI ofPD-1expression (p=0.0108; Figure2G),
a known marker of chronic activation and T cell exhaustion (Day
et al., 2006; Trautmann et al., 2006). Collectively, these data indi-
cate that high amounts of antigenemia during chronic infection
leads to increased caspase-8 activity within ex vivo HIV-specific
CD8+ T cells.
As a control for HIV-specific CD8+ T cells, we also measured
the caspase-8 MFI in cytomegalovirus (CMV)-specific CD8+
T cells and total CD8+ T cell populations (Figure 2H). Analysis
of 18 HLA-A*0201 CPs revealed significantly higher caspase-8
activities present in CD8+ T cells targeting the HLA-A*0201-analysis of variancewas used for comparisonCMV Tet+, HIV Tet+, andHIV Total C
comparison of HIV+ and HIV Total CD8+.
(I) Negative correlation between MFI of caspase-8 activity of HIV tetramer+ CD8+
(n = 13). Correlation statistics for (D), (E), (G), and (I) were calculated using the S
(J) Representative CCR7 andCD45RA staining of total CD8+ T cells (gray) andHIV
(Tcm), effector memory (Tem), and terminal effector (Temra) cells.
(K) Representative FACS plot of KK10 tetramer+ CD8+ T cells identifying caspas
(L–N) Representative histograms of CD45RA, CCR7, and CD27 staining of KK10 te
and total CD8+ T cells (gray).
(O) Summary of phenotypic data for HIV tetramer+ Casp8 and Casp8+ CD8+ T c
mean percentage of HIV tetramer+ Casp8 and Casp8+ CD8+ T cells that were
Wilcoxon matched pairs test.
Immrestricted HIV SL9 epitope in comparison to those directed
against the HLA-A*0201-restricted CMV-specific epitope NV9
(amino acids 495–503; p < 0.01) and the total CD8+ T cell popu-
lation (p < 0.0001). In addition, caspase-8 activity in both HIV
tetramer+ CD8+ T cells and the total CD8+ T cell population of
HIV+ patients was significantly higher than in CD8+ T cells from
seronegative controls (p < 0.05), further indicating a relationship
between antigenic exposure and caspase-8 activity.
Increased Caspase-8 Activity Is Associated with
Impaired HIV-Specific CD8+ T Cell Proliferation
We next assessed the relationship between caspase-8 activity
and proliferative capacity in HIV tetramer+ CD8+ T cells (Fig-
ure 2I). Within a group of 13 individuals, we found a significant
inverse correlation between the percentage of cells that had un-
dergone at least one cell division (Tetramer+ CFSE Lo) and cas-
pase-8 MFI (p = 0.0001). We further characterized the Casp8+
HIV tetramer+ CD8+ T cell pool using a panel of phenotypic
markers associated with CD8+ T cell memory/effector status
(Figures 2J and 2L–2N). Similar to previous work (Hess et al.,
2004), the total HIV tetramer+ CD8+ T cell population exhibited
an effector/effector memory phenotype characterized by low
expression of CD45RA and CCR7 and high expression of
CD27 (Figure 2J). Analysis of Casp8+ HIV tetramer+ CD8+
T cells, however, revealed significantly higher expression of
CD45RA (p < 0.01) and CCR7 (p < 0.05) relative to Casp8 nega-
tive (Casp8) cells (Figures 2L–2O). The increased percentage of
CD45RA+ CCR7 CD27+ within the Casp8+ population was
consistent with an effector memory/terminal effector memory
phenotype (Temra), further associating elevated caspase-8 ac-
tivity with persistent activation and diminished CD8+ T cell prolif-
erative potential. The modest, but significant elevation in CCR7
expression suggested that memory CD8+ T cells, which have
been shown to express low amounts of the caspase-8-inducing
cell surface marker CD95 (Gattinoni et al., 2011), likely also
contribute to the Casp8+ HIV tetramer+ CD8+ T cell pool.
Antigenic StimulationModulates Expression and Spatial
Localization of Caspase-8
Stimulation of the TCR leads to rapid upregulation and transloca-
tion of caspase-8 activity to the plasmamembrane (Koenig et al.,
2008; Misra et al., 2007), which is essential to CD8+ T cell prolif-
eration through suppression of necroptosis. Thus, we examined
whether proliferative differences between EC and CP HIV-
specific CD8+ T cells could be attributed to their differential
ability to upregulate membrane-associated caspase-8 activity
following antigenic stimulation. We established our experimentalD8+ given that thesewere paired observations.Mann-Whitney test was used for
T cells and percentage of CFSE lo tetramer+ cells following peptide stimulation
pearman correlation.
tetramer+ CD8+ T cells (black) from anHIV+CP to identify naive, central memory
e-8 negative (Casp8; red) and positive (Casp8+; blue) cells.
tramer+ Casp8CD8+ T cells (red), KK10 tetramer+ Casp8+ CD8+ T cells (blue),
ells analyzed for CD45RA, CCR7, and CD27 (n = 10). Horizontal bars indicate
positive for the indicated marker. Statistical comparisons were made by the
unity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Inc. 1005
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Figure 3. Effect of Peptide Stimulation on Caspase-8 Activity and Localization in HIV-Specific CD8+ T Cells
(A) Representative data showing modulation in MFI of caspase-8 activity following 1 hr peptide stimulation (1 mg/ml) in KK10-specific CD8+ T cell responses from
an HLA-B*2705 EC and CP. Filled plot (gray) represents caspase-8 MFI in the absence of KK10 peptide and dashed line represents caspase-8 MFI in the
presence of KK10 peptide.
(B) Summary data of change in caspase-8 activity following peptide stimulation in ECs (n = 6), VCs (n = 2), and CPs (n = 8). Statistical comparisons were made
using the Wilcoxon matched pairs test.
(C) Representative plots of Imagestream analysis of KK10 tetramer+ CD8+ T cells from an HLA-B*2705 EC and CP in the presence and absence of KK10 peptide
(1 mg/ml). The Imagestream plots depict total cellular caspase-8 activity on the x axis (Caspase-8 Bright Detail Intensity; Cytoplasmic, yellow) and caspase-8
activity localized in a circular ring located around the edge of the cell on the y axis (Caspase-8 Bright Detail Intensity, Erode; noncytoplasmic, green). Repre-
sentative images corresponding to noncytoplasmic and cytoplasmic caspase-8 cells are shown in the lower panels.
(D) Representative histograms of Imagestream analysis of noncytoplasmic caspase-8 KK10 tetramer+ CD8+ T cells. The histograms depict themaximumpixels of
caspase-8 activity on the x axis, which successfully differentiates caspase-8+ KK10 tetramer+ CD8+ T cells with membrane-associated caspase-8 activity from
those with negative caspase-8 activity. Representative images of membrane-associated caspase-8+ cells are shown in the lower panels.
(E) Summary of percentage of membrane-associated caspase-8+ and cytosolic caspase-8+ KK10 tetramer+ CD8+ T cells within a group of ECs (n = 4) and CPs
(n = 4). Statistical analyses were carried out using the paired t test (intra-patient group comparison, ± peptide) and the Mann-Whitney test (inter-patient group
comparison). See also Figure S3.
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from an HLA-B*2705 EC. Incubation of the clone with an anti-
CD3 antibody for 30 min resulted in increased caspase-8 activity
(Figure S3A). Furthermore, stimulation of the clone with immobi-
lized anti-CD3 and anti-CD28 antibodies resulted in upregulation
and translocation of active caspase-8 molecules to the plasma
membrane, as determined by confocal microscopy and colocal-
ization with the membrane dye FM4-64 (p < 0.01; Figures S3B
and S3C). Using the same approach, peptide stimulation of EC
HIV tetramer+ CD8+ T cells led to a significant increase in cas-1006 Immunity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Inpase-8 activity (p < 0.05), while peptide stimulation of CP cells
resulted in a significant decrease in caspase-8 activity (p <
0.05; Figures 3A and 3B).
To assess the localization of caspase-8 activity within HIV
tetramer+ CD8+ T cells, we used a technique that integrates
quantitative image analysis with flow cytometry into a single plat-
form (Imagestream) (Figures 3C and 3D). We found that CPs had
a higher percentage of HIV tetramer+ CD8+ T cells with cyto-
plasmic caspase-8 activity (p < 0.05), but also a decrease in
this cell population following peptide stimulation (p < 0.05;c.
A B D
EC
Figure 4. Effect of Peptide Stimulation on HIV-Specific CD8+ T Cell Expansion and Induction of Cellular Necrosis
(A) Representative data of change in percentage of KK10 tetramer+ CD8+ T cells upon peptide stimulation in a HLA-B*2705 EC and CP.
(B) Percentage of CFSE lo tetramer+ CD8+ T cells in HLA-B*2705 KK10-specific (filled) and HLA-B*5701 KF11-specifc (open) CD8+ T cell responses in ECs and
CPs. Statistical comparisons were made by the Mann-Whitney test.
(C) Summary data of fold change in tetramer+ CD8+ T cells upon peptide stimulation in HLA-B*2705 KK10-specific (filled) and HLA-B*5701 KF11-specific (open)
CD8+ T cell responses in ECs and CPs presented in (B). Statistical comparisons were made by the Mann-Whitney test.
(D) Representative data of change in percentage of Sytox green Hi KK10 tetramer+ CD8+ T cells upon peptide stimulation in anHLA-B*2705 EC, VC, and CP. Filled
plot (gray) represents Sytox green staining in the absence of KK10 peptide and dashed line represents Sytox green staining in the presence of KK10 peptide.
(E) Summary data of change in percentage of Sytox green Hi HIV tetramer+ CD8+ T cells following peptide stimulation in ECs (n = 6), VCs (n = 4) and CPs (n = 8).
Statistical comparisons were made using the Wilcoxon matched pairs test. See also Figure S4.
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Necroptosis Limits HIV-Specific CTL ProliferationFigure 3E). In contrast, ECHIV tetramer+ CD8+ T cells were found
to have a significant increase in membrane-associated caspase-
8 activity following peptide stimulation (p < 0.05; Figure 3E).
Collectively, these data suggest that HIV-specific CD8+ T cells
from ECs and CPs can be differentiated by their ability and
inability, respectively, to upregulate and translocate caspase-8
to the plasma membrane following antigenic stimulation.
Antigenic Stimulation Induces Necrosis of HIV-Specific
CD8+ T Cells
Given the decreased ability of CP HIV-specific CD8+ T cells to
upregulate membrane-associated caspase-8, we hypothesized
that their reduced proliferative capacity could be due to the acti-
vation of necroptosis following TCR engagement. Thus, we eval-
uated the responses of ten HLA-B*2705 and HLA-B*5701 ECs
and ten HLA-B*2705 and HLA-B*5701 CPs. We found that
6 day cognate peptide stimulation of ECs resulted in a 3.8-fold
increase in HIV tetramer+ CD8+ T cells (p < 0.01; Figures 4A
and 4C). However, the same conditions led to a 1.4-fold
decrease in the frequency of tetramer+ CD8+ T cells in CPs
(p = 0.0015). These data indicate that antigenic stimulation of
CP HIV-specific CD8+ T cells results in significant cell loss.
To evaluate the characteristics of HIV tetramer+ CD8+ T cell
loss, we utilized the necrosis-specific dye Sytox green (Vanden
Berghe et al., 2010). Analysis of the live culture from 20 HIV+ in-
dividuals (Figure S4A), using standard forward scatter and side
scatter parameters, revealed no significant difference in the per-
centage of Sytox green Hi cells between patient groups (Figures
S4B and S4C). However, when the entire culture was analyzed
(Figures S4A–S4C), significant increases in the percentage of
Sytox green Hi HIV tetramer+ CD8+ T cells were appreciated in
peptide-stimulated CP samples (p < 0.01), but not in EC or VC
samples (Figures 4D and 4E). We therefore assessed apoptotic
cell death by quantifying theMFI of executioner caspase-3 activ-Immity in the presence and absence of cognate peptide (Figure S5)
and observed a significant increase in caspase-3 activity in pep-
tide-stimulated HIV tetramer+ CD8+ T cells from ECs, but not
CPs (p < 0.01; Figures S5A and S5B), which is consistent with
its previously defined nonapoptotic role as an early activation
marker during CD8+ T cell expansion (Alam et al., 1999;McComb
et al., 2010).
Blockade of Necroptosis Reverses Defective
HIV-Specific CD8+ T Cell Proliferation
We next examined the role of necroptosis in defective HIV-spe-
cific CD8 T cell proliferation through utilization of necrosis inhib-
itor NecroX-5 (Kim et al., 2010), which has previously been
shown to be effective in reversing RIPK1-RIPK3-induced nec-
roptosis (Roca and Ramakrishnan, 2013). CFSE-labeled PBMCs
were treated with NecroX-5 or DMSO for 1 hr prior to 6 day stim-
ulation with cognate peptide, an example of which is shown for
two HLA-B*2705 chronic progressors (Figure 5A). In these
cases, stimulation with KK10 peptide resulted in a 1.7-fold and
5.5-fold increase in the percentage of HIV tetramer+ CFSE Lo
cells following NecroX-5 preincubation. Similar assays were
performed on a total of 12 chronic progressors, and a significant
increase in the percentage of HIV tetramer+ CFSE Lo cells (p <
0.001) and the expansion of HIV tetramer+ CD8+ T cells (p =
0.025) was observed in the presence of peptide and NecroX-5,
in comparison to the proliferation and expansion of HIV
tetramer+ cells following stimulation with peptide and DMSO
(Figures 5B and 5C).
To further verify the role of necroptosis in dysfunctional HIV-
specific CD8+ T cell proliferation, we depleted the necroptosis
mediator RIPK3 in primary CD8+ T cells using RNA interference
(RNAi). Lentiviruses encoding two distinct short hairpin RNAs
(shRNAs) against RIPK3 and a control shRNA (pLKO Scramble)
were generated and used to transduce primary CD8+ T cellsunity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Inc. 1007
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Figure 5. Blockade of Necroptosis Restores HIV-Specific CD8+ T Cell Proliferation
(A) Representative data of increased proliferation of CFSE-loaded KK10 tetramer+ CD8+ T cells from two HLA-B*2705 CPs in the presence of NecroX-5 (1 mM).
(B) Summary data of change in proliferation of HIV tetramer+ CD8+ T cells in the presence of NecroX-5 in CPs (n = 12). Filled symbols represent HLA-B*2705 KK10
tetramer+ responses and open symbols represent HLA-B*5701 KF11 tetramer+ responses. Statistical analyses were made using the Wilcoxon matched pairs
test.
(C) Summary data of expansion of HIV tetramer+ CD8 T cells in the presence of NecroX-5 in CPs (n = 12). Statistical analyses were made using the Wilcoxon
matched pairs test.
(D) Representative data of increased proliferation of CFSE-loaded KK10 tetramer+ CD8+ T cells from anHLA-B*5701 CP, an HLA-B*2705 CP, and an HLA-B*2705
EC were transduced with lentiviral vectors encoding control shRNA (pLKO Scramble) or two sequence-independent shRNA constructs specific for necroptosis-
activating gene RIPK3 (RIPK3 shRNA #1 and #2).
(E) Primary CD8+ T cells from the three patients in (D) were assessed for RIPK3 protein expression by western blotting following lentiviral transduction and 7 day
puromycin selection. GAPDH was used as a loading control.
(F) Correlation between level of RIPK3 silencing with percentage of HIV tetramer+ CFSE lo CD8+ T cells in patients presented in (D). Expression of RIPK3 was
normalized to GAPDH control.
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Necroptosis Limits HIV-Specific CTL Proliferationfrom a B*2705 CP, a B*5701 CP, and a B*2705 EC. Lentiviral
transduced CD8+ T cells exhibited > 92% viability following pu-
romycin selection. Silencing of RIPK3 expression was assessed
by immunoblotting (Figure 5E). For assessment of HIV-specific
CD8+ T cell proliferation, transduced CD8+ T cells were reconsti-
tuted with autologous non-CD8+ cells, labeled with CFSE, and
stimulated for 6 days with cognate peptide. RIPK3 silencing re-1008 Immunity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Insulted in a dose-dependent increase in the percentage of
CFSE Lo HIV tetramer+ CD8+ T cells in both CP patients; how-
ever, there was no effect in the EC patient (Figure 5F). These
data collectively indicate that blockade of necroptosis, by either
chemical or genetic means, results in an improvement in HIV-
specific CD8+ T cell proliferation in patients with progressive
disease.c.
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While HIV-specificCD8+ T cell proliferation has been shown to be
one of the strongest correlates of immune control in HIV infection
(Ndhlovu et al., 2013), the cellular pathways that account for
these impaired proliferative responses remain poorly under-
stood. In this study, we utilized high-resolution gene expression
profiling and functional immune assays on EC and CP HIV-spe-
cific CD8+ T cells to identify and characterize the roles of cas-
pase-8 and necroptosis in dysfunctional CD8+ T cell proliferation.
To control for differences between patient groups, such as the
differential enrichment of protective and risk alleles, we focused
our transcriptional profiling studies exclusively on CD8+ T cells
specific for the well-characterized HLA-B*2705 Gag p24 KK10
epitope. Analysis of the transcriptional profiles of antigen-stimu-
lated KK10 tetramer+ CD8+ T cells from ECs and CPs revealed
the differential expression of caspase-8 mRNA, while GSEAs
with LCMV-specific CD8+ T cells from acute and chronic infec-
tion validated the statistical reliability of these gene expression
data sets. Application of the protein-protein network analysis
platform DAPPLE, which has previously identified key players
in complex disease states such as rheumatoid arthritis and
Crohn’s disease (Rossin et al., 2011), further implicated the po-
tential association between caspase-8 and defective HIV-spe-
cific CD8+ T cell proliferation.
We therefore validated the upregulation of caspase-8mRNA in
CP HIV tetramer+ CD8+ T cells by qRT-PCR and confirmed its
functional significance through assessment of caspase-8 activity
by flow cytometry. The localization of active caspase-8 within the
cytoplasm of CP cells provided an explanation for the observed
increase in caspase-8 transcripts, as caspase-8 gene expression
is self-inducedby cytoplasmic death effector domains (Yao et al.,
2007). The significant correlations between the caspase-8 MFI in
HIV tetramer+ CD8+ T cells and markers of disease progression
(viral load, CD4+ T cell count) and T cell exhaustion (e.g., PD-1)
suggested a strong relationship between the level of active cas-
pase-8 in HIV-specific CD8+ T cells and the degree of antigenic
exposure. This was further supported by the significant decrease
in caspase-8 activity following the initiation of HAART. These
data were consistent with observations from other chronic infec-
tions such as hepatitis B virus (HBV) and hepatitis C virus (HCV),
which also have elevated levels of caspase-8 activity within their
antigen-specific and bulk CD8+ T cell populations (Radziewicz
et al., 2008; Arends et al., 2011; Peppa et al., 2013).
The negative correlation between the caspase-8 MFI in HIV
tetramer+ CD8+ T cells and the percentage of CFSE Lo cells
following 6 day peptide stimulation was consistent with our
CD8+ T cell phenotyping studies, which revealed an increase in
the percentage of Temra cells (CD45RA+, CCR7, CD27+) within
the Casp8+ pool. In addition, the significant upregulation of
membrane-associated caspase-8 activity following peptide
stimulation in highly proliferative HIV tetramer+ CD8+ T cells
from ECs was consistent with the essential role of caspase-8
in mediating CD8+ T cell proliferation (Salmena et al., 2003; Lev-
errier et al., 2011). This was in contrast to the elevated cyto-
plasmic caspase-8 activity in CP HIV tetramer+ CD8+ T cells
and the inability of these cells to significantly upregulate mem-
brane-associated caspase-8 activity following peptide stimula-
tion. Given that membrane-associated caspase-8 has beenImmshown to form a heterodimer with c-FLIP(L) to promote prolifer-
ation through nuclear factor-kB (NF-kB) activation (Misra et al.,
2007), this suggested that the proliferative defect of CP HIV
tetramer+ CD8+ T cells could simply be due to decreased NF-
kB translocation. However, the decrease in the percentage of
cytoplasmic caspase-8+ HIV tetramer+ CD8+ T cells in CPs
following peptide stimulation also suggested that TCR engage-
ment likely triggers increased cell turnover, which we observed
in an additional set of poorly proliferative CPs.
We initially presumed that the increased cell loss was due to
excessive AICD (Green et al., 2003), in light of previous work
demonstrating that CP HIV-specific CD8+ T cells have increased
apoptotic effector caspase-3 activity and surface annexin V
expression and decreased amounts of antiapoptotic molecule
Bcl-2 (Petrovas et al., 2004; Yan et al., 2013). These notions,
however, were not consistent with the lack of association be-
tween the amount of Fas-induced apoptosis in HIV-specific
CD8+ T cells and either viral load or disease progression (Rega-
mey et al., 1999;Mueller et al., 2001). In addition, we observed no
significant difference in ex vivo caspase-3 activity between HIV
tetramer+ CD8+ T cells and actually found that EC cells signifi-
cantly increased caspase-3 activity following peptide stimula-
tion. This result highlighted recent observations implicating
caspase-3 and annexin V as early markers of CD8+ T cell expan-
sion (Fischer et al., 2006; Alam et al., 1999; McComb et al., 2010)
and suggested that the increased caspase-3 activity in CP cells
could potentially be due to chronic antigenic stimulation. Further-
more, Bcl-2 expression has been shown to be a marker of mem-
ory CD8+ T cells (Dunkle et al., 2013), which may explain its
increased expression in ECs (Yan et al., 2013), given their known
enrichment for HIV-specific CD8+ T cells that display a strong
central memory phenotype (Ndhlovu et al., 2013).
Thus, given the dual role of proapoptotic molecules in CD8+
T cell activation, we considered the potential contribution of
the programmed cell death pathway necroptosis to HIV
tetramer+ CD8+ T cell loss, which has been shown to mediate
CD8+ T cell homeostasis when apoptosis is not completely
effective (Osborn et al., 2010; Han et al., 2011). Necroptosis
plays a critical role in regulating the baseline CD8+ T lymphocyte
pool, as gene-knockout mice that lack necroptosis (Casp8/
Ripk3/) are characterized by a phenotype of severe lymphade-
nopathy, splenomegaly, and increased accumulation of aberrant
B220+ CD3+ T lymphocytes (Oberst et al., 2011). Our results uti-
lizing the necrosis-specific cell dye Sytox green demonstrated
that CPs are enriched for necrotic HIV tetramer+ CD8+ T cells
following antigenic stimulation. The involvement of necroptosis
was further confirmed by the significant improvement in HIV
tetramer+ CD8+ T cell proliferation following pretreatment with
either necrosis inhibitor NecroX-5 or silencing of necroptosis-
mediating enzyme RIPK3. These data revealed that necroptosis
significantly contributes to the proliferative defect of CP HIV-
specific CD8+ T cells and suggest that chronic HIV infection
may potentially drive the normal homeostatic function of
necroptosis to a pathogenic state due to persistent antigenic
stimulation. The result is a rate of cell turnover that cannot be
compensated for by the generation of new virus-specific CD8+
T cells and consequently a ‘‘net deficit’’ in cell proliferation. Of
note, experiments with necroptosis inhibitor Necrostatin-1 did
not reproduce the results of NecroX-5, potentially due to itsunity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Inc. 1009
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Necroptosis Limits HIV-Specific CTL Proliferationoff-target inhibitory effects on the Erk and Jnk pathways that
mediate T cell activation (Cho et al., 2011) and its effects on
the indoleamone-2,3-dioxygenase (IDO)-kynurenine pathway, a
known regulator of CD8+ T cell function (Liu et al., 2009). This ef-
fect was confirmed by the reduction in HIV-specific CD8+ T cell
proliferation of an elite controller pretreated with Necrostatin-1.
Collectively, our data suggest that chronic stimulation of HIV-
specificCD8+ T cells leads to an increase in the basal level of cas-
pase-8 activity within the cellular cytoplasm. However, given that
processed cytoplasmic caspase-8 homodimers are structurally
incapable of forming heterodimers with c-FLIP(L) (Boatright
et al., 2004), the accumulation of caspase-8 in the cytoplasm
may actually result in the depletion of available caspase-8 mole-
cules capable of re-engaging c-FLIP(L) and driving proliferation.
As shown in previous work, the pool of available full-length cas-
pase-8 required for CD8+ T cell activation is in fact reduced in
cells that have elevated levels of cytoplasmic caspase-8 due to
increased caspase-8 proteolysis (Leverrier et al., 2011). Thus,
we propose that CP HIV-specific CD8+ T cells actually exhibit a
pseudo-caspase-8 deficiency phenotype, which is consistent
with the striking similarity between CP cells and CD8+ T cells
frompatientswith homozygous inactivating caspase-8mutations
(i.e., robust proliferation following stimulation with PMA and ion-
omycin, but poor activation following TCR stimulation) (Chun
et al., 2002; Migueles et al., 2008).
In summary, this report identifies caspase-8 and necroptosis
as a correlate and key mediator, respectively, of dysfunctional
HIV-specific CD8+ T cell proliferation in patients with progressive
disease. Caspase-8 and necroptosis have already been impli-
cated in the immunopathology of Crohn’s disease (Gu¨nther
et al., 2011), systemic inflammatory response syndrome (Duprez
et al., 2011), and chronic lymphocytic leukemia (Liu et al., 2012).
Thus, chronic HIV infection may represent another case where
caspase-8 and necroptosis disrupt the finely tuned immune
response, resulting in excessive HIV-specific CD8+ T cell loss
and ineffective immune control. These findings have potential
implications for additional states of persistent antigenemia,
such as HBV and HCV infection, and malignancy. Ultimately,
necroptosis may represent a therapeutic target to enhance
T cell immunity by improving the proliferative potential of anti-
gen-specific CD8+ T cell responses.
EXPERIMENTAL PROCEDURES
Study Subjects
Peripheral blood was obtained from HIV-infected people and HIV-negative
subjects in Boston after institutional review board approval and written
informed consent was obtained. Only cryopreserved PBMCs were used. All
study subjects were HLA typed to four-digit resolution by molecular methods
(Kiepiela et al., 2004). Untreated subjects and people with controlled viremia
on antiviral therapy were enrolled. ‘‘Elite controllers’’ (ECs) were defined as
people who spontaneously controlled viremia to below 50 RNA copies per
ml plasma in the absence of therapy, and viremic controllers (VCs) were
defined as subjects with a viral load of more than 50 and less than 2,000
RNA copies per ml plasma in the absence of treatment. Plasma viral loads
were measured by the HIV-1 Amplicor Monitor Ultrasensitive method (Roche).
Microarray Data Acquisition and Analysis
Sorted tetramer+ CD8+ T cells were pelleted, resuspended in Cell Lysis Buffer
(Ambion), and immediately snap frozen in liquid nitrogen prior to storage at
80C. RNAwas extracted using the RNAqueousMicro Kit (AM1931; Ambion)1010 Immunity 41, 1001–1012, December 18, 2014 ª2014 Elsevier Inaccording to the manufacturer’s instructions. Concentrations of total RNA
were determined with a NanoDrop spectrophotometer. RNA purity was deter-
mined by Bioanalyzer 2100 traces (Agilent Technologies). Total RNA was
amplified by theWT-Ovation Pico RNA Amplification system (NuGEN) accord-
ing to the manufacturer’s directions. Whole-genome transcriptional profiling
was performed using WG-DASL microarrays (Illumina) by the Core Facility at
theWashington University School of Medicine. Data retrieved from the Illumina
software were background corrected (Illumina beadstudio software) and
quantile normalized using the Arraystar normalization function. Analysis was
restricted to genes with significant expression (p < 0.01). Differentially ex-
pressed genes were detected using the empirical Bayes (eBayes) adjusted t
test. Multiple testing was corrected with the Benjamini-Hochberg false discov-
ery rate (FDR). Differentially expressed genes were defined as being at least
1.5-fold different after log2 transformation and having an FDR q value of <
0.05. To correct for batch effect differences between peptide-stimulated
controller and progressor HIV tetramer+ CD8+ T cells, the ratio G method
was utilized with bulk CD8+ T cells used as an internal control as described
previously (Luo et al., 2010).
CFSE Proliferation Assay
PBMCs were first suspended at 106/ml in PBS and incubated at 37C for 7 min
with 0.5 mM carboxyfluorescein succinimidyl ester (CFSE; Molecular Probes).
After the addition of serum and washes with PBS, cells were suspended at
106/ml in medium (RPMI 1640 supplemented with glutamine, 10% human
FCS, penicillin, and streptomycin). No exogenous cytokines were added to
the medium. Individual HIV peptides were added at a final concentration of
10 ng/ml per peptide. On day 6, cells were harvested, washed with PBS,
and stained with APC-labeled dextramers (Immunodex), mAbs (anti-CD3
Alexa 700, anti-CD8 APC Cy7; BD Biosciences), and viability dye (Violet; Mo-
lecular Probes). Cells were then washed and fixed in 1% paraformaldehyde
and subjected to flow cytometric analysis. For reversal experiments, CFSE-
labeled PBMCs were incubated with either NecroX-5 (1 mM; Enzo Life Sci-
ences) or DMSO for 1 hr prior to stimulation with HIV peptide.
Statistical Analysis
The generation of dot plots, nonparametric statistical analysis, analyses of
variance (Kruskal-Wallis, repeated-measures), and correlations (Spearman)
were performed using the statistical programs in GraphPad Prism V.5. Differ-
ences between groups were evaluated by using a Mann-Whitney t test or
ANOVA as indicated. Paired analyses were performed using the Wilcoxon
matched pairs rank test.
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Microarray data sets are available through the Gene Expression Omnibus
(GSE56775, GSE56971).
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